Methoxyamine (MX) potentiates IUdR-induced radiosensitization by enhancing senescence in RKO cells BACK TO THE BEGINNING.

Slides:



Advertisements
Similar presentations
 Since the cell cycle is known, now we must ask what controls it  Noted that healthy cells in contact will not divide ◦ Essentially, this is how our.
Advertisements

2 E Conférence Québécoise Sur La Résistance Thérapeutique du Cancer Q-CROC Montréal, November 5-6, 2010.
P53, Apoptosis, Cancer, More Regulation G1 checkpoint Controlled by G1 Cdk-cyclin G1 cyclin levels also vary with the cell cycle Many additional levels.
Mechanisms of DNA damage-Induced Cell Death Radiobiology 2012.
DNA Repair. Cell Cycle Checkpoint activation DNA Repair: Base Excision Repair Nucleotide excision repair Mismatch repair DSB repair SENESCENCE / APOPTOSIS.
Characterization of a potential new drug in cancer therapy Lab 2 Salah Farag.
APOPTOSIS “Cell Death” By Brian Abadie, Emily Anderson, andJohn Ramsey.
When mammalian cells are subjected to stress signals, oxygen deficiency, radiation, DNA damage, or Chemo- therapeutic drugs, p53 is activated, leading.
Programmed Cell death Saeb Aliwaini April/2013. Introduction Human Body makes 10 billion cells every day. Cell death makes balance : There are various.
Figure S1 A MRC5 Control Chk1 TdR(h): γH2AX Cleaved casp3 RPA34
Lecture 11: Cell proliferation, differentiation, and death Dr. Mamoun Ahram Faculty of Medicine Second year, Second semester, Principles of.
Signaling Pathways Produced By Combining DsRNA with Paclitaxal to treat Ovarian Cancer Switu Patel.
Cellular Senescence: A Link between Tumor Suppression and Organismal Aging.
 Since the cell cycle is known, now we must ask what controls it  Noted that healthy cells in contact will not divide ◦ Essentially, this is how our.
Lecture #3 The Cell Cycle & Cancer
1 H2AX: functional roles and potential applications.
Apoptosis (Programmed Cell Death). Apoptosis vs Necrosis Level of stress, change in environment stress apoptosisnecrosis.
Regulating the Cell Cycle
1 Dr. Karen Schmeichel February 3, 2009 BIO 290 Special Topics in Biology: Cancer Biology Lecture #7 Finishing “Profiling” & “Models Of Cancer”
 Cell cycle is known, so now we ask what controls it  We have observed many factors that influence a cell’s ability to move forward in the cycle ◦ Kinetochores.
 Dr. Steven Grant  Dr. Roberto Rosato  Jorge Almenara  Stefanie Coe  Dr. Allison Johnson, HHMI Coordinator.
Infectivity Enhanced Adenovirus as a Strategy for Improving the Efficiency of RNA Interference in an Ovarian Cancer Model T Michael Numnum, MD International.
1. p53 Structure, Function and Therapeutic Applications Provider: Dr.Davood Nourabadi(PhD,medical physiology) mdphysiology.persianblog.ir.
University of Texas, Southwestern Medical Center, Dallas TX
CENTRE FOR BIOTECHNOLOGY
Molecular methods of cell culture III. Apoptosis  Programmed cell death  A physiological mechanism to eliminate excess, damaged or dangerous cells from.
Section 10.3 (Pg ): Regulating the Cell Cycle
Review of the Cell Cycle. How big is a cell? Answer.
The Response of Tumor Cells to Stress and Chemotherapy The Role of PKC Etta Livneh Faculty of Health Sciences.
Signaling Pathways Produced By Combining DsRNA with Paclitaxal to treat Ovarian Cancer Switu Patel.
HDAC6 : HDAC6 is a cytoplasmic enzyme that regulates many important biological processes. : HDAC6 has recently emerged as a tubulin deacetylase that has.
--Background on Werner’s syndrome --Hayflick His persistence and his ‘limit’ -- Theories of cellular aging -- Introduction to the cell cycle Now: -- More.
--Background on Werner’s syndrome --Hayflick His persistence and his ‘limit’ -- Theories of cellular aging -- Introduction to the cell cycle Now: -- More.
Cancer Accelerated Biology. Learning Objectives The different methods of diagnosing cancer. The difference between a malignant tumor and a benign tumor.
Audeh MW et al. ASCO 2009; Abstract (Clinical Science Symposium)
Lecture 10: Cell cycle Dr. Mamoun Ahram Faculty of Medicine
Cell Cycle Regulation. The Cell Cycle What can be learned from this experiment? There are different signals (proteins) present that aid in the progression.
HOW DO CHECKPOINTS WORK? Checkpoints are governed by phosphorylation activity controlled by CDK’s (cyclin dependent kinases) Checkpoints are governed.
1. 2 Sylvia S. Mader Concepts of Biology © Zanichelli editore, 2012 Sylvia S. Mader Immagini e concetti della biologia.
Targeting of reactive oxygen species can be a potential therapeutic strategy for cancer treatment Ying-Ray Lee 1, San-Yuan Chen 2, and Hau-Ren Chen 3 1.
MELATONIN SENSITIZES HUMAN BREAST CANCER CELLS TO IONIZING RADIATION DEPARTMENT OF PHYSIOLOGY AND PHARMACOLOGY UNIVERSITY OF CANTABRIA, SANTANDER, SPAIN.
Computer modelling using cellular automata of the survival fraction of cell populations under irradiation Morgiane Richard Examples.
Renal Cell Carcinoma: Evaluation of the mitochondrial long non-coding RNA as potential targets for therapy Borgna V.1,2,3, Peña E5, Rivas A1,2,4, Araya.
Targeting the PARP DNA repair pathway enhanced cytotoxicity induced by chemotherapy. Targeting the PARP DNA repair pathway enhanced cytotoxicity induced.
Lecture #3 The Cell Cycle & Cancer
Lecture #4 The Cell Cycle & Cancer
Mismatch Repair Processing of Iododeoxyuridine
Regulating the Cell Cycle
The Cell Cycle and Understanding Cancer
Regulation of Gene Expression
The Zinc Ionophore PCI-5002 Radiosensitizes Non-small Cell Lung Cancer Cells by Enhancing Autophagic Cell Death  Kwang Woon Kim, PhD, Christina K. Speirs,
TNF enhances dose‐dependent cell death following doxorubicin‐induced DNA damage with minimal affect on dose‐dependent cell‐cycle arrest. TNF enhances dose‐dependent.
On the TRAIL to Overcome BRAF-Inhibitor Resistance
DNAPKcs is required for DNA repair in the presence of androgen.
1.
Andrew J. Holland, Don W. Cleveland  Cancer Cell 
Activated membrane signaling promotes survival in response to radiation. Activated membrane signaling promotes survival in response to radiation. Radiation.
Volume 44, Issue 5, Pages (May 2006)
Apoptosis Cell Volume 108, Issue 2, Pages (January 2002)
ATM function in repair of double-stranded DNA breaks.
Keratinocyte Apoptosis Induced by Ultraviolet B Radiation and CD95 Ligation – Differential Protection through Epidermal Growth Factor Receptor Activation.
Signalling pathways and involved entities that are unravelling experimental therapeutic targets for TNBC. Depicted molecular landscape of TNBC confers.
Volume 26, Issue 10, Pages (October 2018)
Simulations to guide drug design strategies for anti–Bcl-2 therapy.
Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. A.
Platinum-based chemotherapy increased TXNIP expression, and overexpression of TXNIP enhanced the effectiveness of this therapy. Platinum-based chemotherapy.
BEZ235 induces accelerated senescence after radiation (IR) in vitro.
Quercetin induces autophagy, blocks cell cycle and activation of ERK and JNK signaling pathways participates in the G1 arrest in P39 cells. Quercetin induces.
WEE1 inhibition followed by TRAIL treatment results in apoptotic cell death in MB231 cells. WEE1 inhibition followed by TRAIL treatment results in apoptotic.
Senescence Elicits Stemness: A Surprising Mechanism for Cancer Relapse
Presentation transcript:

Methoxyamine (MX) potentiates IUdR-induced radiosensitization by enhancing senescence in RKO cells BACK TO THE BEGINNING

Where we began ● Radiation therapy is a major treatment component in the curative management of most human solid tumors. ● Enhancing tumor cell radiosensitivity to achieve better therapeutic gain in cancer treatment has been the ultimate goal in our group. ● IUdR radiosensitization has been in Dr. Kinsella’s research interest during the past twenty years.

Where we are Exploring new adjuvant chemoradiotherapy strategies IUdR + IR: enhancing IR-induced DNA double strand breaks IUdR + MX + IR: DNA BER repair interference IUdR + caffeine/UCN01 + IR: DNA damage G2 checkpoint interference IUdR + HDAC inhibitor + IR: chromatin modification interference

Mechanism underlying the enhanced radiosensitization? IUdR + MX + IR

MX enhances IUdR-DNA incorporation and potentiates IUdR- induced radiosensitization in RKO cells A B Yan T et al. Mol Cancer Ther 5: , 2006

h post-IR Control IUdR IUdR/MX  H2AX β-actin pChk1(S317) pChk2(T68) IUdR/MX pretreatment results in changes in DNA damage signaling following IR Yan T et al. Mol Cancer Ther 5: , 2006

IUdR MX Control IUdR/MX h post-IR % sub-G % sub-G % sub-G % sub-G1 IUdR/MX pretreatment partially suppresses IR-induced apoptotic cell death (sub-G1) Yan T et al. Mol Cancer Ther 5: , 2006 PI

B h post-IR Control IUdR IUdR/MX PARP p85 β-actin A Control IUdR MX IUdR/MX IR 48h IR 72h IUdR/MX pretreatment partially suppresses IR-induced apoptotic cell death (chromatin condensation and PARP cleavage) Yan T et al. Mol Cancer Ther 5: , 2006

Drugs day 2 IR 24h IR 48h IR 72h Control IUdR MX IUdR/MX NT Total PI % 0% IUdR/MX pretreatment appears not to enhance necrotic cell death (PI staining) Yan T et al. Mol Cancer Ther 5: , 2006

h post IR LC3-I α-tubulin LC3-II Control IUdR IUdR/MX IUdR/MX pretreatment appears not to enhance autophagic cell death (LC3-II) Yan T et al. Mol Cancer Ther 5: , 2006

IUdR IUdR/MX 18.8±2.7% 33.6±4.1% IUdR - + A B IUdR/MX pretreatment enhances stress-induced premature senescence following IR MX - + β-gal staining Crystal violet staining Yan T et al. Mol Cancer Ther 5: , 2006

Control IUdR IUdR/MX Hours after IR G1 G2 (high cyclin B1) 4CG1(low cyclin B1) PI Cyclin B1 Cellular characteristics of IUdR/MX/IR-induced senescent cells (4CG1 population) Yan T et al. Mol Cancer Ther 5: , 2006

Control IUdR/MX IUdR Hours post-IR Forward Scatter Cellular characteristics of IUdR/MX/IR-induced senescent cells (enlarged cell size) Yan T et al. Mol Cancer Ther 5: , 2006

p53 p21 actin pRb (S780) hyper-pRb hypo-pRb h post-IR IUdR IUdR/MX Cellular characteristics of IUdR/MX/IR-induced senescent cells (activation of senescence factors) Yan T et al. Mol Cancer Ther 5: , 2006

Conclusion MX potentiates IUdR-induced radiosensitization not by enhancing apoptosis, necrosis and autophagic cell death but by enhancing senescence.

Successful chemotherapy and radiotherapy depend on their ability to trigger tumor cell death Question ● Can we predict the therapeutic efficacy of a cancer treatment strategy using In silico modeling studies? ● Should we model one specific cell death pathway or model all cell death pathways as one entity?

DNA DAMAGE CHECKPOINT ARREST RECOVERY SENESCENCE APOPTOSIS NECROSIS AUTOPHAGY Tumor cell response to DNA damage MITOTIC CATASTROPHE

Complex system Random DNA damages Cell intrinsic characteristics Different types of cell death Overlap Interdependence Crosstalk Shared events Continuum of events Many events are not controlled in transcription level Complex regulation network Simple system Binary cellular decision LIVE/DIE GO/STOP ON/OFF What is the switch? What is the threshold? DNA damage-induced cell death as a system

Question For the modeling of cell death - What are inputs? - What are outputs that are of predictive nature?